FHIR IG analytics| Package | SHIFT-Task-Force.SLS-ValueSets |
| Resource Type | ValueSet |
| Id | ValueSet-SHIFTBHSOMSHIFTBHAGG.json |
| FHIR Version | R4 |
| Source | https://build.fhir.org/ig/SHIFT-Task-Force/SLS-ValueSets/ValueSet-SHIFTBHSOMSHIFTBHAGG.html |
| URL | http://SHIFT-Task-Force.github.io/SLS-ValueSets/ValueSet/SHIFTBHSOMSHIFTBHAGG |
| Version | 0.2.0 |
| Status | active |
| Date | 2026-08-01 |
| Name | SHIFTBHSOMSHIFTBHAGG |
| Title | SHIFT BH SOM | SHIFT BH AGG |
| Realm | uv |
| Description | SHIFT BH SOM: Term is related to a somatization or functional disorder. Use ONLY when the term is exclusively characterized as a somatized or functional disorder; do not apply if the term could also be tagged under another category.; SHIFT BH AGG: Term is related to aggressive or violent behavior, including medications used as chemical restraint, physical restraint procedures, and screening tools for violent behaviors. Excludes terms indicating the patient was the victim of violence; applies only to terms indicating the patient committed or is likely to commit aggressive or violent acts. Purpose of use: identify EHR terms suggesting the patient may have a history of, or be prone to, aggressive or violent behavior. RxNorm-specific scope: include only chemical-restraint medications/formulations (typically short-acting IM forms - IM haloperidol short-acting, IM ziprasidone, IM olanzapine short-acting, IM aripiprazole short-acting, IM droperidol, IM chlorpromazine, IM lorazepam, IM midazolam, IM diphenhydramine in restraint cocktails, IM ketamine for severe agitation). Cross-tag with SHIFT BH CORE only when the same formulation is also routinely used for daily BH treatment (e.g., IM lorazepam = AGG | CORE). PO forms of these molecules go in BH CORE only. Long-acting depot injectables (haloperidol decanoate, olanzapine pamoate, paliperidone palmitate, aripiprazole long-acting) go in BH CORE only - they are maintenance, not chemical restraint. Identified as: ShiftCustomActSensitivityCodes#BHSOM, ShiftCustomActSensitivityCodes#BHAGG |
No resources found
| CodeSystem | ||
| fhir.tx.support#1.0.1 | icd-10-cm | International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet SHIFTBHSOMSHIFTBHAGG
Profile: SHIFT SLS ValueSet Profile
This value set expansion contains 1 concepts.
| System | Code | Display |
http://hl7.org/fhir/sid/icd-10-cm | F68.A |
{
"resourceType": "ValueSet",
"id": "SHIFTBHSOMSHIFTBHAGG",
"meta": {
"profile": [
"http://SHIFT-Task-Force.github.io/SLS-ValueSets/StructureDefinition/ShiftSlsValueSet"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "http://SHIFT-Task-Force.github.io/SLS-ValueSets/ValueSet/SHIFTBHSOMSHIFTBHAGG",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:1.3.6.1.4.1.66281.3.1.48.33"
}
],
"version": "0.2.0",
"name": "SHIFTBHSOMSHIFTBHAGG",
"title": "SHIFT BH SOM | SHIFT BH AGG",
"status": "active",
"experimental": false,
"date": "2026-08-01",
"publisher": "SHIFT-Task-Force",
"contact": [
{
"name": "SHIFT-Task-Force",
"telecom": [
{
"system": "url",
"value": "https://www.shiftinterop.org/"
}
]
}
],
"description": "SHIFT BH SOM: Term is related to a somatization or functional disorder. Use ONLY when the term is exclusively characterized as a somatized or functional disorder; do not apply if the term could also be tagged under another category.; SHIFT BH AGG: Term is related to aggressive or violent behavior, including medications used as chemical restraint, physical restraint procedures, and screening tools for violent behaviors. Excludes terms indicating the patient was the victim of violence; applies only to terms indicating the patient committed or is likely to commit aggressive or violent acts. Purpose of use: identify EHR terms suggesting the patient may have a history of, or be prone to, aggressive or violent behavior. RxNorm-specific scope: include only chemical-restraint medications/formulations (typically short-acting IM forms - IM haloperidol short-acting, IM ziprasidone, IM olanzapine short-acting, IM aripiprazole short-acting, IM droperidol, IM chlorpromazine, IM lorazepam, IM midazolam, IM diphenhydramine in restraint cocktails, IM ketamine for severe agitation). Cross-tag with SHIFT BH CORE only when the same formulation is also routinely used for daily BH treatment (e.g., IM lorazepam = AGG | CORE). PO forms of these molecules go in BH CORE only. Long-acting depot injectables (haloperidol decanoate, olanzapine pamoate, paliperidone palmitate, aripiprazole long-acting) go in BH CORE only - they are maintenance, not chemical restraint.\n\nIdentified as: ShiftCustomActSensitivityCodes#BHSOM, ShiftCustomActSensitivityCodes#BHAGG",
"useContext": [
{
"code": {
"system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
"code": "focus"
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://SHIFT-Task-Force.github.io/SLS-ValueSets/CodeSystem/ShiftCustomActSensitivityCodes",
"code": "BHSOM"
}
]
}
},
{
"code": {
"system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
"code": "focus"
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://SHIFT-Task-Force.github.io/SLS-ValueSets/CodeSystem/ShiftCustomActSensitivityCodes",
"code": "BHAGG"
}
]
}
}
],
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001"
}
]
}
],
"compose": {
"inactive": true,
"include": [
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"concept": [
{
"code": "F68.A",
"display": "Factitious disorder imposed on another"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:fe3262f7-b26e-4f9b-afed-1475083be53e",
"timestamp": "2026-09-17T11:42:30-05:00",
"parameter": [
{
"name": "used-codesystem",
"valueUri": "http://hl7.org/fhir/sid/icd-10-cm"
}
],
"contains": [
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"code": "F68.A"
}
]
}
}